Silvant Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,975
| Closed | -$89K | – | 314 |
|
|
2022
Q3 | $89K | Hold |
3,975
| – | – | 0.01% | 260 |
|
|
2022
Q2 | $99K | Hold |
3,975
| – | – | 0.02% | 209 |
|
|
2022
Q1 | $154K | Hold |
3,975
| – | – | 0.03% | 191 |
|
|
2021
Q4 | $233K | Sell |
3,975
-255
| -6% | -$14.9K | 0.04% | 171 |
|
|
2021
Q3 | $251K | Hold |
4,230
| – | – | 0.04% | 169 |
|
|
2021
Q2 | $367K | Hold |
4,230
| – | – | 0.06% | 144 |
|
|
2021
Q1 | $349K | Hold |
4,230
| – | – | 0.06% | 148 |
|
|
2020
Q4 | $385K | Hold |
4,230
| – | – | 0.07% | 147 |
|
|
2020
Q3 | $169K | Buy |
4,230
+1,436
| +51% | +$57.4K | 0.03% | 184 |
|
|
2020
Q2 | $96K | Buy |
+2,794
| New | +$96K | 0.02% | 216 |
|